The National Agency for Food and Drug Administration and Control, NAFDAC, has approved Oxford/AstraZeneca COVID-19 vaccine for use in Nigeria.
The vaccine, according to the agency can be stored at 2 to 8-degree centigrade.
NAFDAC Director-General, Dr. Mojisola Adeyeye disclosed this while briefing newsman in Abuja on Thursday.
She said the agency got the dossier of the vaccine a week ago to which its safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.
Dr Adeyeys said there are three additional vaccines undergoing evaluation, but the evaluation on Astrazeneca shows that the vaccine is effective against the UK variant of the virus which has been reported in Nigeria.
Recall that the World Health Organisation, WHO recently approved the AstraZeneca vaccine for COVID-19 treatment.
The Oxford/AstraZeneca vaccine, also known as ChAdOx1 nCoV-19, or AZD1222, is a viral vector vaccine.